Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Experimental Melanomas”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Testing effectiveness (Phase 2)Looking for participantsNCT07070232
What this trial is testing

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 1,438
Testing effectiveness (Phase 2)Study completedNCT04700072
What this trial is testing

Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 56
Not applicableStudy completedNCT03693378
What this trial is testing

IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

Who this might be right for
Pancreatic Ductal AdenocarcinomaFamilial Pancreatic CancerFAMMM - Familial Atypical Mole Malignant Melanoma Syndrome
Immunovia, Inc. 1,349
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)WithdrawnNCT02763761
What this trial is testing

An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo

Who this might be right for
Renal Cell CarcinomaMelanomaLung Cancer
Bristol-Myers Squibb
Early research (Phase 1)Ended earlyNCT02711345
What this trial is testing

A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers.

Who this might be right for
Ovarian NeoplasmsNon-Small-Cell Lung CarcinomaMelanoma+1 more
Novartis Pharmaceuticals 65
Testing effectiveness (Phase 2)Study completedNCT04305041
What this trial is testing

Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 100
Testing effectiveness (Phase 2)Study completedNCT02658890
What this trial is testing

An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread

Who this might be right for
Advanced CancerMelanomaNon-Small Cell Lung Cancer
Bristol-Myers Squibb 627
Not applicableEnrolling By InvitationNCT00068003
What this trial is testing

Harvesting Cells for Experimental Cancer Treatments

Who this might be right for
MelanomaGastrointestinal CancerMetastatic Cancer+2 more
National Cancer Institute (NCI) 7,000
Large-scale testing (Phase 3)Study completedNCT01106040
What this trial is testing

Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes

Who this might be right for
Breast CancerMelanoma
Navidea Biopharmaceuticals 163
Early research (Phase 1)Study completedNCT04165967
What this trial is testing

Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma

Who this might be right for
Advanced Melanoma
University Hospital, Basel, Switzerland 9
Testing effectiveness (Phase 2)Study completedNCT02320058
What this trial is testing

An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself

Who this might be right for
Melanoma
Bristol-Myers Squibb 119
Testing effectiveness (Phase 2)WithdrawnNCT05572463
What this trial is testing

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma

Who this might be right for
Unresectable Cutaneous MelanomaMetastatic Cutaneous Melanoma
Innovent Biologics (Suzhou) Co. Ltd.
Large-scale testing (Phase 3)Study completedNCT03329846
What this trial is testing

An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma

Who this might be right for
MelanomaSkin Cancer
Bristol-Myers Squibb 20
Testing effectiveness (Phase 2)Study completedNCT04305054
What this trial is testing

Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 335
Very early researchStudy completedNCT00972933
What this trial is testing

Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma

Who this might be right for
Melanoma
Diwakar Davar 59
Testing effectiveness (Phase 2)Study completedNCT00044356
What this trial is testing

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Who this might be right for
MelanomaMetastatic MelanomaMalignant Melanoma+1 more
Vical 133
Early research (Phase 1)Study completedNCT01295931
What this trial is testing

Nuclear and Near-Infrared (NIR) Imaging in Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT01065441
What this trial is testing

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

Who this might be right for
Solid Tumors Stage II, Stage III and Stage IVBreast CancerColorectal Cancer+5 more
Michael Har-Noy 9
Testing effectiveness (Phase 2)Study completedNCT00513604
What this trial is testing

Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental+1 more
National Cancer Institute (NCI) 158
Next Page